1. Radiosensitizing effect of 5-aminolevulinic acid in colorectal cancer in vitro and in vivo
- Author
-
Hisashi Ikoma, Yasutoshi Murayama, Tomohiro Arita, Toshiyuki Kosuga, Atsushi Shiozaki, Eigo Otsuji, Yoshiaki Kuriu, Masayoshi Nakanishi, Ryo Morimura, Takeshi Kubota, Hirotaka Konishi, Hitoshi Fujiwara, Kazuto Yamada, Kazuma Okamoto, and Yosuke Kamada
- Subjects
0301 basic medicine ,Cancer Research ,Colorectal cancer ,medicine.medical_treatment ,Intraperitoneal injection ,colorectal cancer ,03 medical and health sciences ,0302 clinical medicine ,In vivo ,Glioma ,medicine ,protoporphyrin IX ,Radiosensitivity ,radiotherapy ,business.industry ,Melanoma ,radiosensitizing effect ,Cancer ,Articles ,medicine.disease ,Radiation therapy ,030104 developmental biology ,Oncology ,5-aminolevulinic acid ,radiosensitivity ,030220 oncology & carcinogenesis ,Cancer research ,business - Abstract
The radiosensitizing effect of 5-aminolevulinic acid (5-ALA) has been demonstrated in glioma and melanoma in a number of studies. Enhancing the radiosensitivity of colorectal cancer may improve survival rates and lessen adverse effects. The present study assessed the radiosensitizing effect of 5-ALA in colorectal cancer using the human colon cancer cell line HT29 in vitro and in vivo. In vitro, cells were pretreated with 5-ALA and exposed to ionizing radiation. Cells pretreated with or without 5-ALA were compared using a colony formation assay. In vivo, HT29 cells were implanted into mice subcutaneously and subsequently exposed to ionizing radiation. 5-ALA was administrated by intraperitoneal injection. Subcutaneous tumors treated with or without 5-ALA were compared. Single-dose and multi-dose irradiations were applied both in vitro and in vivo. Cells exposed to multi-dose irradiation and pretreated with 5-ALA in vitro had a significantly lower surviving fraction compared with cells without 5-ALA pretreatment. Following multi-dose irradiation in vivo, the volume of the subcutaneous tumors treated with 5-ALA was significantly lower compared with that of tumors without treatment. These results suggest that radiotherapy with 5-ALA may enhance the therapeutic effect in colon cancer.
- Published
- 2019